Health ❯ Healthcare ❯ Pharmaceuticals ❯ Weight Loss

Obesity Treatments

GLP-1 Agonists Linked to Small Rise in Diabetic Retinopathy and Rare Optic-Nerve Events

Clinicians now recommend regular ophthalmic screening after large observational studies uncovered these associations

Novo Nordisk Launches Wegovy Weight-Loss Drug in India

Novo Nordisk’s Amycretin Delivers Up to 24% Early Weight Loss in Dual-Form Trials

Trump's Executive Order Targets U.S. Drug Price Disparities

Tirzepatide Outperforms Semaglutide in Weight-Loss Trial

UK to Trial Pharmacy-Based NHS Weight-Loss Jab Prescriptions

Growing Demand for Weight-Loss Drugs in the UK Raises Safety and Accessibility Concerns

Zepbound Outperforms Wegovy in Weight Loss Clinical Trial